Table 2.
Marker | Time points | Survivor | Non-survivor | p |
---|---|---|---|---|
Nu H3.1 (ng/ml) | D1/2 | 1333,14 (385.14–3637.92) | 1919 (880.75–12,098.9) | 0.006 |
D3/4 | 662 (378.59–2151.88) | 1391.5 (655.8–4186.9) | 0.01 | |
D6/8 | 530.72 (225.9–960.4) | 605.9 (429.3–1851.7) | 0.12 | |
IL-6 (pg/ml) | D1/2 | 745 (245–2849.50) | 1859.5 (611.5–19,198.5) | 0.004 |
D3/4 | 96 (40–178) | 259 (86.25–484.5) | 0.0002 | |
D6/8 | 54.9 (31.5–106.58) | 100 35.92–300.75) | 0.09 | |
mHLA-DR (ABC) | D1/2 | 3793 (2682–6662) | 5104 (3136–8374) | 0.04 |
D3/4 | 4093 (3128–7172) | 3731 (2320–5924) | 0.15 | |
D6/8 | 7252 (4793–9939) | 4762 (2700–6391) | 0.009 | |
Lymphocyte (G/L) | D1/2 | 0.905 (0.500–1.600) | 1.05 (0.61–1.56) | 0.40 |
D3/4 | 0.9 (0.600–1.215) | 0.73 (0.500–1.200) | 0.53 | |
D6/8 | 1.03 (0.900–1.200) | 1.100 (0.800–1.600) | 0.76 |
Results at different time points as median and (interquartile range). p Mann–Whitney test